Advertisement

Ads Placeholder
Loading...

Valneva SE

INRLF•PNK
Healthcare
Biotechnology
$2.90
$0.00(0.00%)
U.S. Market opens in 5h 2m

Valneva SE (INRLF) Stock Overview

Explore Valneva SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap499.1M
P/E Ratio-3.73
EPS (TTM)$-0.78
ROE-0.75%
Fundamental Analysis

AI Price Forecasts

1 Month$5.03
3 Months$6.24
1 Year Target$4.52

INRLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Valneva SE (INRLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 18.54, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $4.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.73 and a market capitalization of 499.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-43.14%
3-Month Change
-39.83%
6-Month Change
-47.65%
Year-to-Date (YTD) Change
-28.40%
1-Year Change
-0.68%
3-Year Change
-48.49%
5-Year Change
-80.00%
All-Time (Max) Change
-90.17%

Contact Information

https://valneva.com
33 2 28 07 37 10
6 rue Alain Bombard, Saint-Herblain, NaN, 44800

Company Facts

7,130 Employees
IPO DateApr 23, 2010
CountryFR
Actively Trading

Frequently Asked Questions